A randomized phase II/III trial of conventional paclitaxel and carboplatin with/without bevacizumab versus dose-dense paclitaxel and carboplatin with/without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Results of the phase II part.

被引：0
|
作者：
Ishikawa, Mitsuya
Kitagawa, Ryo
Shibata, Taro
Tokunaga, Hideki
Iwata, Takashi
Nishio, Shin
Takada, Toshio
Mori, Masahiko
Horie, Koji
Kudaka, Wataru
Kagabu, Masahiro
Tanikawa, Michihiro
Kobayashi, Hiroaki
Yaegashi, Nobuo
机构：
[1] Natl Canc Ctr, Dept Gynecol, Tokyo, Japan
[2] Moriya Daiichi Gen Hosp, Dept Gynecol & Obstet, Ibaraki, Japan
[3] Natl Canc Ctr, Operat Off, Japan Clin Oncol Grp Data Ctr, Tokyo, Japan
[4] Tohoku Univ Hosp, Dept Gynecol, Sendai, Miyagi, Japan
[5] Keio Univ, Dept Obstet & Gynecol, Sch Med, Tokyo, Japan
[6] Kurume Univ, Dept Obstet & Gynecol, Sch Med, Kurume, Fukuoka, Japan
[7] Kitasato Univ, Dept Obstet & Gynecol, Sch Med, Sagamihara, Kanagawa, Japan
[8] Aichi Canc Ctr Hosp, Dept Gynecol Oncol, Nagoya, Aichi, Japan
[9] Saitama Canc Ctr, Dept Gynecol, Saitama, Japan
[10] Univ Ryukyus, Grad Sch Med Sci, Dept Obstet & Gynecol, Nishihara, Okinawa, Japan
[11] Iwate Med Univ, Dept Obstet & Gynecol, Sch Med, Morioka, Iwate, Japan
[12] Univ Tokyo, Dept Obstet & Gynecol, Tokyo, Japan
[13] Kagoshima Univ, Fac Med, Dept Obstet & Gynecol, Kagoshima, Japan
[14] Tohoku Univ, Dept Obstet & Gynecol, Grad Sch Med, Sendai, Miyagi, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6027
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A phase II evaluation of carboplatin/paclitaxel/bevacizumab in the treatment of advanced-stage endometrial carcinoma: Report of toxicity
    OMalley, D.
    Gary, P.
    Salani, R.
    Eisenhauer, E.
    Fowler, J.
    Copeland, L.
    Cohn, D.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S33 - S33
  • [22] A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer
    Zhu, T.
    Liu, C. L.
    Zhang, Y. F.
    Liu, Y. H.
    Xu, F. P.
    Zu, J.
    Zhang, G. C.
    Li, X. R.
    Liao, N.
    Wang, K.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (01) : 117 - 124
  • [23] A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer
    T. Zhu
    C. L. Liu
    Y. F. Zhang
    Y. H. Liu
    F. P. Xu
    J. Zu
    G. C. Zhang
    X. R. Li
    N. Liao
    K. Wang
    Breast Cancer Research and Treatment, 2016, 156 : 117 - 124
  • [24] A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)
    Saito, Isamu
    Kitagawa, Ryo
    Fukuda, Haruhiko
    Shibata, Taro
    Katsumata, Noriyuki
    Konishi, Ikuo
    Yoshikawa, Hiroyuki
    Kamura, Toshiharu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (01) : 90 - 93
  • [25] Phase II trial of paclitaxel (T) and carboplatin (C) in patients with recurrent or metastatic cervical carcinoma.
    Kitagawa, R
    Katsumata, N
    Yamanaka, Y
    Ando, M
    Fujiwara, Y
    Kasamatsu, T
    Onda, T
    Yamada, T
    Tsunematsu, R
    Watanabe, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 461S - 461S
  • [26] Randomized phase II trial of carboplatin-paclitaxel (CP) compared to carboplatin-paclitaxel-bevacizumab (CP-B) in advanced (stage III-IV) or recurrent endometrial cancer: The MITO END-2 trial.
    Lorusso, Domenica
    Ferrandina, Gabriella
    Colombo, Nicoletta
    Pignata, Sandro
    Salutari, Vanda
    Maltese, Giuseppina
    Pisano, Carmela
    Lapresa, Maria
    Savarese, Antonella
    Tagliaferri, Pierosandro
    Sorio, Roberto
    Cinieri, Saverio
    Breda, Enrico
    Sabbatini, Roberto
    Lepori, Stefano
    Conte, Carmine
    Cecere, Sabrina Chiara
    Raspagliesi, Francesco
    Scambia, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
    Kitagawa, Ryo
    Katsumata, Noriyuki
    Shibata, Taro
    Kamura, Toshiharu
    Kasamatsu, Takahiro
    Nakanishi, Toru
    Nishimura, Sadako
    Ushijima, Kimio
    Takano, Masashi
    Satoh, Toyomi
    Yoshikawa, Hiroyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (19) : 2129 - U151
  • [28] A phase II study of dose-dense neoadjuvant chemotherapy with weekly paclitaxel and carboplatin followed by chemoradiation in locally advanced cervical carcinoma.
    Singh, Rajkumar Bikramjit
    Kumar, Lalit
    Chandra, Subhash
    Mohanti, B. K.
    Pathy, Sushmita
    Kumar, K. Sunesh
    Bhatla, Neerja
    Thulkar, Sanjay
    Vishnubhatla, Sreenivas
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] MITO 25.1: A RANDOMIZED, MOLECULAR DRIVEN PHASE II TRIAL OF CARBOPLATIN-PACLITAXEL-BEVACIZUMAB VS CARBOPLATIN-PACLITAXEL-BEVACIZUMAB-RUCAPARIB VS CARBOPLATIN-PACLITAXEL-RUCAPARIB, SELECTED ACCORDING TO HRD STATUS, IN PATIENTS WITH ADVANCED OVARIAN CANCER
    Musacchio, Lucia
    Salutari, Vanda
    Pignata, Sandro
    Valabrega, Giorgio
    Zavallone, Laura
    Cormio, Gennaro
    Mosconi, Anna Maria
    Giolitto, Serena
    Camarda, Floriana
    Ricci, Caterina
    Zamagni, Claudio
    Nero, Camilla
    Carbone, Maria Vittoria
    Ghizzoni, Viola
    Sorio, Roberto
    Salvatore, Siena
    Tronconi, Francesca
    Savarese, Antonella
    Scambia, Giovanni
    Lorusso, Domenica
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A239 - A239
  • [30] Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079)
    Tanigawa, Terumi
    Takeshima, Nobuhiro
    Ishikawa, Hideki
    Nishio, Shin
    Usami, Tomoka
    Yamawaki, Takaharu
    Oishi, Tetsuro
    Ihira, Kei
    Kato, Hisamori
    Goto, Mayako
    Saito, Motoaki
    Taira, Yusuke
    Yokoyama, Masatoshi
    Shoji, Tadahiro
    Kondo, Eiji
    Mori, Atsushi
    Yokoi, Takeshi
    Iwasa-Inoue, Naomi
    Hirashima, Yasuyuki
    Nagasawa, Takayuki
    Takenaka, Motoki
    Mikami, Mikio
    Sugiyama, Toru
    Enomoto, Takayuki
    GYNECOLOGIC ONCOLOGY, 2022, 165 (03) : 413 - 419
12345